CX Institutional’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24K Buy
2,567
+23
+0.9% +$257 ﹤0.01% 1135
2026
Q1
$28K Buy
2,544
+25
+1% +$214 ﹤0.01% 1073
2025
Q4
$15K Buy
2,519
+32
+1% +$191 ﹤0.01% 1139
2025
Q3
$13K Hold
2,487
﹤0.01% 1164
2025
Q2
$15K Hold
2,487
﹤0.01% 998
2025
Q1
$20K Sell
2,487
-34,064
-93% -$286K ﹤0.01% 942
2024
Q4
$302K Buy
36,551
+12,538
+52% +$101K 0.01% 440
2024
Q3
$184K Sell
24,013
-85,793
-78% -$790K 0.01% 544
2024
Q2
$1.14M Sell
109,806
-1,563
-1% -$17.1K 0.05% 262
2024
Q1
$1.33M Buy
+111,369
New +$1.24M 0.06% 240
2020
Q4
Sell
-234
Closed -$1K 903
2020
Q3
$1K Buy
+234
New +$861 ﹤0.01% 860

Other funds holding PTEN

CX Institutional's PTEN Position: Q2 2026 in Review

CX Institutional increased its Patterson-UTI (PTEN) stake by 0.9% in Q2 2026, buying an estimated $257 and bringing the position to 2,567 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #1135.

CX Institutional first reported a position in PTEN in Q3 2020 and has held it in 11 quarters since. The position peaked at $1.33M in Q1 2024. 438 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • CX Institutional held 2,567 shares of Patterson-UTI worth $24K as of Q2 2026.
  • CX Institutional bought 23 Patterson-UTI shares in Q2 2026, an estimated $257.
  • Patterson-UTI made up ﹤0.01% of CX Institutional's portfolio in Q2 2026, its #1135 holding.
  • CX Institutional first reported a position in Patterson-UTI in Q3 2020 and has held it in 11 quarters since.
  • CX Institutional's Patterson-UTI position peaked at $1.33M in Q1 2024.
  • 438 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.